168 related articles for article (PubMed ID: 35091681)
1. Loss of NFE2L3 protects against inflammation-induced colorectal cancer through modulation of the tumor microenvironment.
Saliba J; Coutaud B; Makhani K; Epstein Roth N; Jackson J; Park JY; Gagnon N; Costa P; Jeyakumar T; Bury M; Beauchemin N; Mann KK; Blank V
Oncogene; 2022 Mar; 41(11):1563-1575. PubMed ID: 35091681
[TBL] [Abstract][Full Text] [Related]
2. NFE2L3 Controls Colon Cancer Cell Growth through Regulation of DUX4, a CDK1 Inhibitor.
Bury M; Le Calvé B; Lessard F; Dal Maso T; Saliba J; Michiels C; Ferbeyre G; Blank V
Cell Rep; 2019 Nov; 29(6):1469-1481.e9. PubMed ID: 31693889
[TBL] [Abstract][Full Text] [Related]
3. NFE2L3 as a Potential Functional Gene Regulating Immune Microenvironment in Human Kidney Cancer.
Zhang Q; Tang D; Zha A; He J; Li D; Chen Y; Cai W; Dai J; Luan S; Yin L; Zhang W; Dai Y
Biomed Res Int; 2022; 2022():9085186. PubMed ID: 36337840
[TBL] [Abstract][Full Text] [Related]
4. NFE2L3 Inhibition Induces Cell Cycle Arrest at the G0/G1 Phase in Colorectal Cancer Cells through Downregulating CCND1 and pRb1-ser807/811.
Zhang L; Hu DL; Tang B; Cheng Y; Jiao C; Cheng L; Tan ZR; Zhou HH
Dis Markers; 2019; 2019():2829798. PubMed ID: 31191746
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
[TBL] [Abstract][Full Text] [Related]
6. NFE2L1 and NFE2L3 Complementarily Maintain Basal Proteasome Activity in Cancer Cells through CPEB3-Mediated Translational Repression.
Waku T; Katayama H; Hiraoka M; Hatanaka A; Nakamura N; Tanaka Y; Tamura N; Watanabe A; Kobayashi A
Mol Cell Biol; 2020 Jun; 40(14):. PubMed ID: 32366381
[TBL] [Abstract][Full Text] [Related]
7. PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.
Vidotto T; Saggioro FP; Jamaspishvili T; Chesca DL; Picanço de Albuquerque CG; Reis RB; Graham CH; Berman DM; Siemens DR; Squire JA; Koti M
Prostate; 2019 Jun; 79(9):969-979. PubMed ID: 30999388
[TBL] [Abstract][Full Text] [Related]
8. Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 exhibits tumor-suppressing effects in hepatocellular carcinoma cells.
Yu MM; Feng YH; Zheng L; Zhang J; Luo GH
World J Gastroenterol; 2019 Mar; 25(10):1210-1223. PubMed ID: 30886504
[TBL] [Abstract][Full Text] [Related]
9. NFE2L3 (NRF3): the Cinderella of the Cap'n'Collar transcription factors.
Chevillard G; Blank V
Cell Mol Life Sci; 2011 Oct; 68(20):3337-48. PubMed ID: 21687990
[TBL] [Abstract][Full Text] [Related]
10. STAT6 Is Critical for the Induction of Regulatory T Cells In Vivo Controlling the Initial Steps of Colitis-Associated Cancer.
Delgado-Ramirez Y; Ocaña-Soriano A; Ledesma-Soto Y; Olguín JE; Hernandez-Ruiz J; Terrazas LI; Leon-Cabrera S
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919941
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of NFE2L3 predicts the poor prognosis of pancreatic cancer patients.
Wang H; Zhan M; Yang R; Shi Y; Liu Q; Wang J
Cell Cycle; 2018; 17(17):2164-2174. PubMed ID: 30196752
[TBL] [Abstract][Full Text] [Related]
12. CD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative Colitis.
Butera A; Sanchez M; Pronio A; Amendola A; De Nitto D; Di Carlo N; Lande R; Frasca L; Borrini F; Pica R; Boirivant M
Front Immunol; 2018; 9():2511. PubMed ID: 30425718
[No Abstract] [Full Text] [Related]
13. NFE2L3 promotes tumor progression and predicts a poor prognosis of bladder cancer.
Qian J; Huang C; Zhu Z; He Y; Wang Y; Feng N; He S; Li X; Zhou L; Zhang C; Gong Y
Carcinogenesis; 2022 Jun; 43(5):457-468. PubMed ID: 35022660
[TBL] [Abstract][Full Text] [Related]
14. IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas.
Cui G; Li Z; Ren J; Yuan A
Virchows Arch; 2019 Nov; 475(5):579-586. PubMed ID: 31062086
[TBL] [Abstract][Full Text] [Related]
15. Identification roles of NFE2L3 in digestive system cancers.
Li F; Wen Z
J Cancer Res Clin Oncol; 2024 Mar; 150(3):150. PubMed ID: 38514488
[TBL] [Abstract][Full Text] [Related]
16. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance.
Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T-cell Genes Drive Altered Immune Microenvironment in Adult Solid Cancers and Allow for Immune Contextual Patient Subtyping.
Brouwer-Visser J; Cheng WY; Bauer-Mehren A; Maisel D; Lechner K; Andersson E; Dudley JT; Milletti F
Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):103-112. PubMed ID: 29133367
[No Abstract] [Full Text] [Related]
18. Stringent Control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) Protein Degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and Glycogen Synthase Kinase 3 (GSK3).
Kannan MB; Dodard-Friedman I; Blank V
J Biol Chem; 2015 Oct; 290(43):26292-302. PubMed ID: 26306035
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of NFE2L3 promotes the development of gastric cancer through epithelial-mesenchymal transformation.
Wang X; Li Y; Fang Z; Li Y
Bioengineered; 2021 Dec; 12(2):12204-12214. PubMed ID: 34783304
[TBL] [Abstract][Full Text] [Related]
20. Tumor Infiltrating Regulatory T Cells in Sporadic and Colitis-Associated Colorectal Cancer: The Red Little Riding Hood and the Wolf.
Fantini MC; Favale A; Onali S; Facciotti F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
